| Mr Jonathan E Williams, MD | |
|
1240 Huffman Mill Rd, Burlington, NC 27215-8700 | |
| (336) 538-7064 | |
| (336) 538-7041 |
| Full Name | Mr Jonathan E Williams |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1240 Huffman Mill Rd, Burlington, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982636510 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 2006-00611 (North Carolina) | Primary |
| 208D00000X | General Practice | 2006-00611 (North Carolina) | Secondary |
| Entity Name | Wake Forest University Health Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003803032 PECOS PAC ID: 4486564952 Enrollment ID: O20031105000436 |
News Archive
Ricerca Biosciences, LLC, announced today the finalization of the acquisition of the Discovery and Preclinical business of MDS Pharma Services with facilities and almost 600 associates in Bothell, Washington; Lyon, France; and Taipei, Taiwan.
When amounts of a small protein called TCTP (translationally controlled tumor protein) are reduced in the cells of fruit flies, they are smaller than normal, indicating that the protein plays a major role in the growth and proliferation of cells, said researchers at Baylor College of Medicine in a report in current issue of the journal Nature.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launch of novel therapies for the treatment of Hepatitis C Virus (HCV), including Vertex/Johnson & Johnson/Mitsubishi Tanabe's telaprevir and Merck's boceprevir, will precipitate several changes in HCV treatment.
Information collected from individual patients at doctor's office and hospital visits could be used to improve health care and reduce costs on a national scale, according to a discussion paper released by the Institute of Medicine.
› Verified 3 days ago
| Entity Name | Alamance Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326010273 PECOS PAC ID: 5294647145 Enrollment ID: O20040504000878 |
News Archive
Ricerca Biosciences, LLC, announced today the finalization of the acquisition of the Discovery and Preclinical business of MDS Pharma Services with facilities and almost 600 associates in Bothell, Washington; Lyon, France; and Taipei, Taiwan.
When amounts of a small protein called TCTP (translationally controlled tumor protein) are reduced in the cells of fruit flies, they are smaller than normal, indicating that the protein plays a major role in the growth and proliferation of cells, said researchers at Baylor College of Medicine in a report in current issue of the journal Nature.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launch of novel therapies for the treatment of Hepatitis C Virus (HCV), including Vertex/Johnson & Johnson/Mitsubishi Tanabe's telaprevir and Merck's boceprevir, will precipitate several changes in HCV treatment.
Information collected from individual patients at doctor's office and hospital visits could be used to improve health care and reduce costs on a national scale, according to a discussion paper released by the Institute of Medicine.
› Verified 3 days ago
| Entity Name | Wake Forest Emergency Providers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396216735 PECOS PAC ID: 7012819816 Enrollment ID: O20190312003619 |
News Archive
Ricerca Biosciences, LLC, announced today the finalization of the acquisition of the Discovery and Preclinical business of MDS Pharma Services with facilities and almost 600 associates in Bothell, Washington; Lyon, France; and Taipei, Taiwan.
When amounts of a small protein called TCTP (translationally controlled tumor protein) are reduced in the cells of fruit flies, they are smaller than normal, indicating that the protein plays a major role in the growth and proliferation of cells, said researchers at Baylor College of Medicine in a report in current issue of the journal Nature.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launch of novel therapies for the treatment of Hepatitis C Virus (HCV), including Vertex/Johnson & Johnson/Mitsubishi Tanabe's telaprevir and Merck's boceprevir, will precipitate several changes in HCV treatment.
Information collected from individual patients at doctor's office and hospital visits could be used to improve health care and reduce costs on a national scale, according to a discussion paper released by the Institute of Medicine.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jonathan E Williams, MD Janice Hecht Department Of Emergency, Wake Forest Baptist Health Medical Center Blvd., Winston Salem, NC 27157-0001 Ph: (336) 716-1896 | Mr Jonathan E Williams, MD 1240 Huffman Mill Rd, Burlington, NC 27215-8700 Ph: (336) 538-7064 |
News Archive
Ricerca Biosciences, LLC, announced today the finalization of the acquisition of the Discovery and Preclinical business of MDS Pharma Services with facilities and almost 600 associates in Bothell, Washington; Lyon, France; and Taipei, Taiwan.
When amounts of a small protein called TCTP (translationally controlled tumor protein) are reduced in the cells of fruit flies, they are smaller than normal, indicating that the protein plays a major role in the growth and proliferation of cells, said researchers at Baylor College of Medicine in a report in current issue of the journal Nature.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launch of novel therapies for the treatment of Hepatitis C Virus (HCV), including Vertex/Johnson & Johnson/Mitsubishi Tanabe's telaprevir and Merck's boceprevir, will precipitate several changes in HCV treatment.
Information collected from individual patients at doctor's office and hospital visits could be used to improve health care and reduce costs on a national scale, according to a discussion paper released by the Institute of Medicine.
› Verified 3 days ago
Mary Funke, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1240 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-538-7000 | |
Dr. Anne-caroline M Garnier Norman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1240 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-716-2255 | |
Dr. Randolph Nicholas Brown, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1240 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-716-2255 | |
Paul Malinda, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1240 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-538-7050 Fax: 336-538-7041 | |
Caitlin Jernigan Rodgers, PA-C Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1240 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-538-7000 | |
Dr. Linda M Taylor, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1240 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-716-2255 | |
James Donald Strickland, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2708 Sturbridge Court, Burlington, NC 27215 Phone: 336-585-0938 |